Pain News and Research

Latest Pain News and Research

Patients with degenerative spondylolisthesis do not benefit from epidural steroid injections

Researchers at the Rothman Institute at Jefferson examined data on patients being treated for lumbar stenosis and the degenerative spine condition spondylolisthesis and found that patients who received epidural steroid injections (ESI) had a higher rate of crossover to surgery and fared worse in physical health and bodily pain versus those who did not receive ESI, dispelling their pre-study hypothesis.

8 Feb 2012

Question for cardiologists has far-reaching implications for health care costs

The affordability of American medical care in the future will depend, in part, on the ability of physicians to simplify and economize, which are two things they've never been good at. With national health expenditures amounting to $2.6 trillion a year - 45 percent of it paid by government - prosperity and political stability may also be at stake.

8 Feb 2012

FDA accepts Genentech's pertuzumab BLA and grants Priority Review

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application for pertuzumab and granted Priority Review.

8 Feb 2012

FDA reviews Amgen’s prostate cancer drug Xgeva

U.S. Food and Drug Administration (FDA) researchers say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.

7 Feb 2012

Ultrasound makes arthritis evaluation and treatment quicker and more accurate

Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.

7 Feb 2012

Short spinning session can induce troponin T in healthy people

A short spinning session can trigger the same biochemical indications as a heart attack - a reaction that is probably both natural and harmless, but should be borne in mind when people seek emergency treatment for chest pain, reveals a study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

7 Feb 2012

Five coping strategies can help people to overcome dental fear

Scientists at the Sahlgrenska Academy, University of Gothenburg, Sweden, have investigated the strategies used by people who suffer from dental fear to cope with dental treatment. Some of the most important factors in managing stress during a visit to the dentist include optimism on the part of the patient and an atmosphere of humour in the interaction with the dental staff.

7 Feb 2012

Book focuses on Group Schema Therapy for BPD

Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".

7 Feb 2012

EpiCept seeks FDA Fast Track designation for AmiKet to treat CIPN

EpiCept Corporation today announced that it has filed for Fast Track designation for AmiKet(amitriptyline 4%, ketamine 2% cream) for the treatment for chemotherapy-induced peripheral neuropathy (CIPN) with the U.S. Food and Drug Administration.

7 Feb 2012

COC pill alleviates symptoms of painful menstrual periods

A large Scandinavian study, that has been running for 30 years, has finally provided convincing evidence that the combined oral contraceptive pill does, indeed, alleviate the symptoms of painful menstrual periods reports scientists from the University of Gothenburg, Sweden.

7 Feb 2012

Mylan acquires two dermatological drugs from Valeant

Mylan Inc. today announced that it has successfully completed the acquisition of two dermatological products from Valeant Pharmaceuticals.

6 Feb 2012

Researchers describe genetic basis of endometriosis

Researchers at Yale School of Medicine have, for the first time, described the genetic basis of endometriosis, a condition affecting millions of women that is marked by chronic pelvic pain and infertility. The researchers' discovery of a new gene mutation provides hope for new screening methods.

6 Feb 2012

Successful six organ transplants in 9 year old

A 9 year old girl from Maine is making recovery days after surgeons transplanted six of her organs in a groundbreaking medical procedure.

6 Feb 2012

Free, online community for oncology nurses

UBM Medica, a recognized leader in medical media and education, and UBM DeusM, the integrated services arm of UBM, today announced the launch of The Oncology Nurse Community (www.theONC.org), a free, online community exclusively for oncology nurses and the cancer care teams that support them.

6 Feb 2012

Comprehensive program to help reduce health risks of narcotics drugs on injured workers

Accident Fund Holdings, Inc. recently created a comprehensive narcotics program to help reduce the health risks of these drugs on injured workers and ultimately provide a mechanism for them to get back to work sooner.

6 Feb 2012

Emergent Financial Group raises $11.8M for Tenex Health

Emergent Financial Group, Inc. today announced the completion of a $11.8 million private placement transaction for Tenex Health Inc., a California-based medical technology company developing the FAST Procedure (Focused Aspiration of Scar Tissue) for the treatment of tendon injuries.

6 Feb 2012

BioLineRx, Genoscience and RFS Pharma enter agreement for BL-8030 Hepatitis C treatment

BioLineRx, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.

6 Feb 2012

Clinuvel submits SCENESSE MAA to EMA for treatment of erythropoietic protoporphyria

Clinuvel Pharmaceuticals Limited today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class drug SCENESSE (afamelanotide 16mg implant) to the European Medicines Agency.

6 Feb 2012

Viewpoints: Komen takes a lashing; Is the safety net really intact?; Romney assails HHS' rule on contraception

With its roster of corporate sponsors and the pink ribbons that lend a halo to almost any kind of product you can think of, the Susan G. Komen for the Cure foundation has a longstanding reputation as a staunch protector of women's health. That reputation suffered a grievous, perhaps mortal, wound this week from the news that Komen, the world's largest breast cancer organization, decided to betray that mission.

5 Feb 2012

Study to evaluate vitaminD3, omega3 and home exercise in preventing age-related chronic diseases

In Europe, the number of seniors aged 70 and over will increase by 40% in the next 20 years, while those aged 80 and over will more than double. Health authorities and the medical community expect a corresponding increase in the number of people suffering costly and debilitating age-related chronic diseases such as osteoporosis, arthritis, heart and lung diseases and dementia.

3 Feb 2012